{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:56:57Z","timestamp":1782856617394,"version":"3.54.5"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STE 1872\/4-1"],"award-info":[{"award-number":["STE 1872\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STE 1872\/4-1"],"award-info":[{"award-number":["STE 1872\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    More than 80% of patients who meet clinical criteria for hereditary breast and ovarian cancer (HBOC) do not show pathogenic variants in\n                    <jats:italic>BRCA1, BRCA2<\/jats:italic>\n                    , and other diagnostically consented core genes. We hypothesized that variants in further DNA repair genes, cryptic genomic alterations, or polygenic factors may explain HBOC risk. We studied 134 patients with breast cancer and\/or ovarian cancer by the use of whole genome sequencing (WGS), whole transcriptome sequencing (WTS), optical genome mapping (OGM), and mobile element analysis. We identified (likely) pathogenic variants in DNA repair genes in 18 patients, including several RECQ helicase and other DNA repair genes, an intragenic\n                    <jats:italic>FANCM<\/jats:italic>\n                    deletion, and six rare mobile element insertions (MEIs) in DNA repair genes. Incorporating PRS306 shifted estimated lifetime breast cancer risk by \u22655 percentage points in a subset of women (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200975), including carriers of rare variants in DNA repair genes, resulting in both upward and downward risk estimation.\n                  <\/jats:p>","DOI":"10.1038\/s41523-026-01003-1","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:47:38Z","timestamp":1782852458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics analysis in suspected hereditary breast and ovarian cancer cases reveals novel candidate susceptibility factors"],"prefix":"10.1038","volume":"12","author":[{"given":"B. Aldrige","family":"Allister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"L\u00fchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Wendeburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Auber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Morlot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Wallaschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"di Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schlegelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika M.","family":"Golas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8797-0816","authenticated-orcid":false,"given":"Doris","family":"Steinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"1003_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4137\/BCBCR.S18715","volume":"8","author":"MJ Larsen","year":"2014","unstructured":"Larsen, M. J., Thomassen, M., Gerdes, A.-M. & Kruse, T. A. Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer Basic Clin. Res. 8, 145\u2013155 (2014).","journal-title":"Breast Cancer Basic Clin. Res."},{"key":"1003_CR2","doi-asserted-by":"publisher","first-page":"341723","DOI":"10.1155\/2015\/341723","volume":"2015","author":"A Toss","year":"2015","unstructured":"Toss, A. et al. Hereditary ovarian cancer: not only BRCA 1 and 2 genes. BioMed. Res. Int. 2015, 341723 (2015).","journal-title":"BioMed. Res. Int."},{"key":"1003_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/genes15020219","volume":"15","author":"V Barili","year":"2024","unstructured":"Barili, V. et al. Genetic basis of breast and ovarian cancer: approaches and lessons learnt from three decades of inherited predisposition testing. Genes 15, 219 (2024).","journal-title":"Genes"},{"key":"1003_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5946-0","volume":"19","author":"I Sepahi","year":"2019","unstructured":"Sepahi, I. et al. Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women. BMC Cancer 19, 787 (2019).","journal-title":"BMC Cancer"},{"key":"1003_CR5","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker, K. B. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317, 2402 (2017).","journal-title":"JAMA"},{"key":"1003_CR6","unstructured":"Deutsches Konsortium Famili\u00e4rer Brust- und Eierstockkrebs | Konsortium FBEK | Uniklinik K\u00f6ln. https:\/\/www.konsortium-familiaerer-brustkrebs.de\/."},{"key":"1003_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11229-y","volume":"23","author":"A \u00d6fverholm","year":"2023","unstructured":"\u00d6fverholm, A. et al. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer 23, 738 (2023).","journal-title":"BMC Cancer"},{"key":"1003_CR8","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/ijc.31921","volume":"144","author":"E Girard","year":"2019","unstructured":"Girard, E. et al. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing. Int. J. Cancer 144, 1962\u20131974 (2019).","journal-title":"Int. J. Cancer"},{"key":"1003_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0652-y","volume":"13","author":"S da Costa e Silva Carvalho","year":"2020","unstructured":"da Costa e Silva Carvalho, S. et al. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21-gene panel in the Brazilian population. BMC Med. Genomics 13, 21 (2020).","journal-title":"BMC Med. Genomics"},{"key":"1003_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/humu.24158","volume":"42","author":"PS Felicio","year":"2021","unstructured":"Felicio, P. S. et al. Whole-exome sequencing of non-BRCA1\/BRCA2 mutation carrier cases at high-risk for hereditary breast\/ovarian cancer. Hum. Mutat. 42, 290\u2013299 (2021).","journal-title":"Hum. Mutat."},{"key":"1003_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01957-9","volume":"27","author":"D Aguilar","year":"2025","unstructured":"Aguilar, D. et al. Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population. Breast Cancer Res 27, 7 (2025).","journal-title":"Breast Cancer Res"},{"key":"1003_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10549-012-2357-1","volume":"137","author":"D Prokofyeva","year":"2013","unstructured":"Prokofyeva, D. et al. Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom\u2019s syndrome, is associated with breast cancer in Slavic populations. Breast Cancer Res. Treat. 137, 533\u2013539 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"1003_CR13","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1073\/pnas.1418631112","volume":"112","author":"A Belkadi","year":"2015","unstructured":"Belkadi, A. et al. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proc. Natl. Acad. Sci. Usa. 112, 5473\u20135478 (2015).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"1003_CR14","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/genes12121958","volume":"12","author":"P Dremsek","year":"2021","unstructured":"Dremsek, P. et al. Optical genome mapping in routine human genetic diagnostics\u2014its advantages and limitations. Genes 12, 1958 (2021).","journal-title":"Genes"},{"key":"1003_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41431-022-01145-3","volume":"30","author":"A McNeill","year":"2022","unstructured":"McNeill, A. Exome sequencing\u2014one test to rule them all?. Eur. J. Hum. Genet. 30, 869\u2013869 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"1003_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-016-0065-9","volume":"7","author":"DC Hancks","year":"2016","unstructured":"Hancks, D. C. & Kazazian, H. H. Roles for retrotransposon insertions in human disease. Mob. DNA 7, 9 (2016).","journal-title":"Mob. DNA"},{"key":"1003_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41436-020-0749-x","volume":"22","author":"RI Torene","year":"2020","unstructured":"Torene, R. I. et al. Mobile element insertion detection in 89,874 clinical exomes. Genet. Med. 22, 974\u2013978 (2020).","journal-title":"Genet. Med."},{"key":"1003_CR18","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1101\/gr.218032.116","volume":"27","author":"EJ Gardner","year":"2017","unstructured":"Gardner, E. J. et al. The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology. Genome Res 27, 1916\u20131929 (2017).","journal-title":"Genome Res"},{"key":"1003_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0488-x","volume":"15","author":"DT Thung","year":"2014","unstructured":"Thung, D. T. et al. Mobster: accurate detection of mobile element insertions in next generation sequencing data. Genome Biol. 15, 488 (2014).","journal-title":"Genome Biol."},{"key":"1003_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41431-023-01478-7","volume":"32","author":"R Wijngaard","year":"2024","unstructured":"Wijngaard, R. et al. Mobile element insertions in rare diseases: a comparative benchmark and reanalysis of 60,000 exome samples. Eur. J. Hum. Genet. 32, 200\u2013208 (2024).","journal-title":"Eur. J. Hum. Genet."},{"key":"1003_CR21","doi-asserted-by":"publisher","first-page":"6623515","DOI":"10.1155\/2023\/6623515","volume":"2023","author":"J Klein","year":"2023","unstructured":"Klein, J. et al. A Novel Alu Element Insertion in ATM Induces Exon Skipping in Suspected HBOC Patients. Hum. Mutat. 2023, 6623515 (2023).","journal-title":"Hum. Mutat."},{"key":"1003_CR22","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cancers17071056","volume":"17","author":"P Padrik","year":"2025","unstructured":"Padrik, P. et al. Guidance for the clinical use of the breast cancer polygenic risk scores. Cancers 17, 1056 (2025).","journal-title":"Cancers"},{"key":"1003_CR23","doi-asserted-by":"publisher","first-page":"117822342312057","DOI":"10.1177\/11782234231205700","volume":"17","author":"P Padrik","year":"2023","unstructured":"Padrik, P. et al. Implementation of risk-stratified breast cancer prevention with a polygenic risk score test in clinical practice. Breast Cancer Basic Clin. Res. 17, 11782234231205700 (2023).","journal-title":"Breast Cancer Basic Clin. Res."},{"key":"1003_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13058-025-02107-5","volume":"27","author":"A Kvist","year":"2025","unstructured":"Kvist, A. et al. Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer. Breast Cancer Res. BCR 27, 160 (2025).","journal-title":"Breast Cancer Res. BCR"},{"key":"1003_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ajhg.2020.09.001","volume":"107","author":"I Kramer","year":"2020","unstructured":"Kramer, I. et al. Breast cancer polygenic risk score and contralateral breast cancer risk. Am. J. Hum. Genet. 107, 837\u2013848 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"1003_CR26","first-page":"1726","volume":"23","author":"IMM Lakeman","year":"2021","unstructured":"Lakeman, I. M. M. et al. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. Genet. Med. J. Am. Coll. Med. Genet. 23, 1726\u20131737 (2021).","journal-title":"Genet. Med. J. Am. Coll. Med. Genet."},{"key":"1003_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.breast.2023.01.003","volume":"67","author":"E Roberts","year":"2023","unstructured":"Roberts, E., Howell, S. & Evans, D. G. Polygenic risk scores and breast cancer risk prediction. Breast. 67, 71\u201377 (2023).","journal-title":"Breast"},{"key":"1003_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat, N. et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am. J. Hum. Genet. 104, 21\u201334 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"1003_CR29","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41436-020-0862-x","volume":"22","author":"DR Barnes","year":"2020","unstructured":"Barnes, D. R. et al. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genet. Med. 22, 1653\u20131666 (2020).","journal-title":"Genet. Med."},{"key":"1003_CR30","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41436-021-01198-7","volume":"23","author":"IMM Lakeman","year":"2021","unstructured":"Lakeman, I. M. M. et al. The predictive ability of the 313 variant\u2013based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. Genet. Med. 23, 1726\u20131737 (2021).","journal-title":"Genet. Med."},{"key":"1003_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41431-024-01647-2","volume":"32","author":"A Baumann","year":"2024","unstructured":"Baumann, A. et al. Limitations in next-generation sequencing-based genotyping of breast cancer polygenic risk score loci. Eur. J. Hum. Genet. 32, 987\u2013997 (2024).","journal-title":"Eur. J. Hum. Genet."},{"key":"1003_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/apt.16826","volume":"55","author":"K Curtius","year":"2022","unstructured":"Curtius, K., Gupta, S. & Boland, C. R. Lynch Syndrome - a mechanistic and clinical management update. Aliment. Pharmacol. Ther. 55, 960\u2013977 (2022).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1003_CR33","first-page":"30004","volume":"3","author":"H Chen","year":"2014","unstructured":"Chen, H., Zhang, S. & Wu, Z. Fanconi anemia pathway defects in inherited and sporadic cancers. Transl. Pediatr. 3, 30004\u201330304 (2014).","journal-title":"Transl. Pediatr."},{"key":"1003_CR34","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/cancers12040829","volume":"12","author":"J del Valle","year":"2020","unstructured":"del Valle, J. et al. Exploring the role of mutations in fanconi anemia genes in hereditary cancer patients. Cancers 12, 829 (2020).","journal-title":"Cancers"},{"key":"1003_CR35","doi-asserted-by":"publisher","unstructured":"Zong, Y. Werner Syndrome Helicase (WRN) Gene Variants and Cancer in Japanese Elderly: An Autopsy Study. https:\/\/doi.org\/10.23937\/2469-5858\/1510103","DOI":"10.23937\/2469-5858\/1510103"},{"key":"1003_CR36","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.1407909111","volume":"111","author":"JI Kiiski","year":"2014","unstructured":"Kiiski, J. I. et al. Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer. Proc. Natl. Acad. Sci. 111, 15172\u201315177 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1003_CR37","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.3390\/ijms24065612","volume":"24","author":"B Otahalova","year":"2023","unstructured":"Otahalova, B. et al. Importance of germline and somatic alterations in human MRE11, RAD50, and NBN genes coding for MRN Complex. Int. J. Mol. Sci. 24, 5612 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1003_CR38","doi-asserted-by":"publisher","first-page":"e1003008","DOI":"10.1371\/journal.pgen.1003008","volume":"8","author":"NA Ellis","year":"2012","unstructured":"Ellis, N. A. & Offit, K. Heterozygous mutations in DNA repair genes and hereditary breast cancer: a question of power. PLoS Genet 8, e1003008 (2012).","journal-title":"PLoS Genet"},{"key":"1003_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep14060","volume":"5","author":"RM de Voer","year":"2015","unstructured":"de Voer, R. M. et al. Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer. Sci. Rep. 5, 14060 (2015).","journal-title":"Sci. Rep."},{"key":"1003_CR40","doi-asserted-by":"publisher","first-page":"e202000668","DOI":"10.26508\/lsa.202000668","volume":"3","author":"B Benedict","year":"2020","unstructured":"Benedict, B. et al. The RECQL helicase prevents replication fork collapse during replication stress. Life Sci. Alliance 3, e202000668 (2020).","journal-title":"Life Sci. Alliance"},{"key":"1003_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s004390050599","volume":"101","author":"CE Ogburn","year":"1997","unstructured":"Ogburn, C. E. et al. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum. Genet. 101, 121\u2013125 (1997).","journal-title":"Hum. Genet."},{"key":"1003_CR42","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1126\/science.1074340","volume":"297","author":"KH Goss","year":"2002","unstructured":"Goss, K. H. et al. Enhanced tumor formation in mice heterozygous for Blm mutation. Science 297, 2051\u20132053 (2002).","journal-title":"Science"},{"key":"1003_CR43","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/nar\/28.2.648","volume":"28","author":"MJ Moser","year":"2000","unstructured":"Moser, M. J. et al. WRN helicase expression in Werner syndrome cell lines. Nucleic Acids Res 28, 648\u2013654 (2000).","journal-title":"Nucleic Acids Res"},{"key":"1003_CR44","doi-asserted-by":"publisher","first-page":"640755","DOI":"10.3389\/fcell.2021.640755","volume":"9","author":"H Lu","year":"2021","unstructured":"Lu, H. & Davis, A. J. Human RecQ Helicases in DNA double-strand break repair. Front. Cell Dev. Biol. 9, 640755 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1003_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005228","volume":"11","author":"J Sun","year":"2015","unstructured":"Sun, J. et al. Mutations in RECQL gene are associated with predisposition to breast cancer. PLoS Genet 11, e1005228 (2015).","journal-title":"PLoS Genet"},{"key":"1003_CR46","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1073\/pnas.100448097","volume":"97","author":"JK Karow","year":"2000","unstructured":"Karow, J. K., Constantinou, A., Li, J. L., West, S. C. & Hickson, I. D. The Bloom\u2019s syndrome gene product promotes branch migration of holliday junctions. Proc. Natl. Acad. Sci. Usa. 97, 6504\u20136508 (2000).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"1003_CR47","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1038\/sj.emboj.7600277","volume":"23","author":"P Pichierri","year":"2004","unstructured":"Pichierri, P., Franchitto, A. & Rosselli, F. BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. EMBO J. 23, 3154\u20133163 (2004).","journal-title":"EMBO J."},{"key":"1003_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10689-014-9748-x","volume":"14","author":"N Bogdanova","year":"2015","unstructured":"Bogdanova, N. et al. Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe. Fam. Cancer 14, 145\u2013149 (2015).","journal-title":"Fam. Cancer"},{"key":"1003_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.molcel.2015.09.012","volume":"60","author":"RA Schwab","year":"2015","unstructured":"Schwab, R. A. et al. The Fanconi anemia pathway maintains genome stability by coordinating replication and transcription. Mol. Cell 60, 351\u2013361 (2015).","journal-title":"Mol. Cell"},{"key":"1003_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13578-016-0134-2","volume":"7","author":"A Palovcak","year":"2017","unstructured":"Palovcak, A., Liu, W., Yuan, F. & Zhang, Y. Maintenance of genome stability by Fanconi anemia proteins. Cell Biosci. 7, 8 (2017).","journal-title":"Cell Biosci."},{"key":"1003_CR51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature11863","volume":"493","author":"MC Kottemann","year":"2013","unstructured":"Kottemann, M. C. & Smogorzewska, A. Fanconi anemia and the repair of Watson and Crick crosslinks. Nature 493, 356\u2013363 (2013).","journal-title":"Nature"},{"key":"1003_CR52","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fcell.2020.00160","volume":"8","author":"C-B Fang","year":"2020","unstructured":"Fang, C.-B., Wu, H.-T., Zhang, M.-L., Liu, J. & Zhang, G.-J. Fanconi Anemia Pathway: Mechanisms Of Breast Cancer Predisposition Development And Potential Therapeutic Targets. Front. Cell Dev. Biol. 8, 160 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1003_CR53","first-page":"245","volume":"12","author":"N Petrucelli","year":"2010","unstructured":"Petrucelli, N., Daly, M. B. & Feldman, G. L. Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. Genet. Med. J. Am. Coll. Med. Genet. 12, 245\u2013259 (2010).","journal-title":"Genet. Med. J. Am. Coll. Med. Genet."},{"key":"1003_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clbc.2021.08.001","volume":"22","author":"P Gianni","year":"2022","unstructured":"Gianni, P. et al. The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data. Clin. Breast Cancer 22, 10\u201325 (2022).","journal-title":"Clin. Breast Cancer"},{"key":"1003_CR55","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaoncol.2016.5592","volume":"3","author":"G Neidhardt","year":"2017","unstructured":"Neidhardt, G. et al. Association between loss-of-function mutations within the FANCM gene and early-onset familial breast cancer. JAMA Oncol. 3, 1245\u20131248 (2017).","journal-title":"JAMA Oncol."},{"key":"1003_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-019-0127-5","volume":"5","author":"G Figlioli","year":"2019","unstructured":"Figlioli, G. et al. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. NPJ Breast Cancer 5, 38 (2019).","journal-title":"NPJ Breast Cancer"},{"key":"1003_CR57","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1093\/hmg\/ddv251","volume":"24","author":"P Peterlongo","year":"2015","unstructured":"Peterlongo, P. et al. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. Hum. Mol. Genet 24, 5345\u20135355 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"1003_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.breast.2017.12.013","volume":"38","author":"V Silvestri","year":"2018","unstructured":"Silvestri, V. et al. A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy. Breast 38, 92\u201397 (2018).","journal-title":"Breast"},{"key":"1003_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10549-025-07634-5","volume":"211","author":"A Tervasm\u00e4ki","year":"2025","unstructured":"Tervasm\u00e4ki, A. et al. Population-based study of recurrent DNA damage response gene variants in breast cancer cases. Breast Cancer Res. Treat. 211, 195\u2013202 (2025).","journal-title":"Breast Cancer Res. Treat."},{"key":"1003_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00766-9","volume":"7","author":"T Mantere","year":"2017","unstructured":"Mantere, T. et al. Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility. Sci. Rep. 7, 681 (2017).","journal-title":"Sci. Rep."},{"key":"1003_CR61","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1086\/517616","volume":"80","author":"R Kalb","year":"2007","unstructured":"Kalb, R. et al. Hypomorphic mutations in the gene encoding a key Fanconi Anemia Protein, FANCD2, sustain a significant group of FA-D2 Patients with severe phenotype. Am. J. Hum. Genet. 80, 895\u2013910 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"1003_CR62","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10689-012-9553-3","volume":"11","author":"S Smetsers","year":"2012","unstructured":"Smetsers, S. et al. Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma. Fam. Cancer 11, 661\u2013665 (2012).","journal-title":"Fam. Cancer"},{"key":"1003_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-020-01057-3","volume":"21","author":"D Nie","year":"2020","unstructured":"Nie, D. et al. Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies. BMC Med. Genet. 21, 118 (2020).","journal-title":"BMC Med. Genet."},{"key":"1003_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71884-4","volume":"14","author":"LM Rodrigues","year":"2024","unstructured":"Rodrigues, L. M. et al. Prevalence of germline variants in Brazilian pancreatic carcinoma patients. Sci. Rep. 14, 21083 (2024).","journal-title":"Sci. Rep."},{"key":"1003_CR65","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/nar\/gkm033","volume":"35","author":"RK Nookala","year":"2007","unstructured":"Nookala, R. K., Hussain, S. & Pellegrini, L. Insights into Fanconi Anaemia from the structure of human FANCE. Nucleic Acids Res. 35, 1638\u20131648 (2007).","journal-title":"Nucleic Acids Res."},{"key":"1003_CR66","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1074\/jbc.M113.533976","volume":"289","author":"D Polito","year":"2014","unstructured":"Polito, D. et al. The Carboxyl Terminus of FANCE Recruits FANCD2 to the Fanconi Anemia (FA) E3 Ligase Complex to Promote the FA DNA Repair Pathway. J. Biol. Chem. 289, 7003\u20137010 (2014).","journal-title":"J. Biol. Chem."},{"key":"1003_CR67","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1093\/emboj\/cdf355","volume":"21","author":"P Pace","year":"2002","unstructured":"Pace, P. et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21, 3414\u20133423 (2002).","journal-title":"EMBO J."},{"key":"1003_CR68","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.dnarep.2006.01.005","volume":"5","author":"F L\u00e9veill\u00e9","year":"2006","unstructured":"L\u00e9veill\u00e9, F. et al. The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC. DNA Repair 5, 556\u2013565 (2006).","journal-title":"DNA Repair"},{"key":"1003_CR69","doi-asserted-by":"publisher","first-page":"10646","DOI":"10.1073\/pnas.1220921110","volume":"110","author":"L Wan","year":"2013","unstructured":"Wan, L. et al. Scaffolding protein SPIDR\/KIAA0146 connects the Bloom syndrome helicase with homologous recombination repair. Proc. Natl. Acad. Sci. USA 110, 10646\u201310651 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1003_CR70","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/cge.14080","volume":"101","author":"A Heddar","year":"2022","unstructured":"Heddar, A., Guichoux, N., Auger, N. & Misrahi, M. A SPIDR homozygous nonsense pathogenic variant in isolated primary ovarian insufficiency with chromosomal instability. Clin. Genet. 101, 242\u2013246 (2022).","journal-title":"Clin. Genet."},{"key":"1003_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41431-021-00982-y","volume":"30","author":"S Neuser","year":"2022","unstructured":"Neuser, S. et al. Prenatal phenotype of PNKP-related primary microcephaly associated with variants affecting both the FHA and phosphatase domain. Eur. J. Hum. Genet. 30, 101\u2013110 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"1003_CR72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1055\/s-0039-1684008","volume":"8","author":"GE Rudenskaya","year":"2019","unstructured":"Rudenskaya, G. E. et al. Ataxia with Oculomotor Apraxia Type 4 with PNKP Common \u201cPortuguese\u201d and Novel Mutations in Two Belarusian Families. J. Pediatr. Genet. 8, 58\u201362 (2019).","journal-title":"J. Pediatr. Genet."},{"key":"1003_CR73","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1093\/nar\/gkaa489","volume":"48","author":"I Kalasova","year":"2020","unstructured":"Kalasova, I. et al. Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair. Nucleic Acids Res. 48, 6672\u20136684 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1003_CR74","doi-asserted-by":"publisher","first-page":"21022","DOI":"10.1073\/pnas.1112036108","volume":"108","author":"N Coquelle","year":"2011","unstructured":"Coquelle, N., Havali-Shahriari, Z., Bernstein, N., Green, R. & Glover, J. N. M. Structural basis for the phosphatase activity of polynucleotide kinase\/phosphatase on single- and double-stranded DNA substrates. Proc. Natl. Acad. Sci. 108, 21022\u201321027 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1003_CR75","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000295","volume":"4","author":"M Sedghi","year":"2018","unstructured":"Sedghi, M. et al. Ataxia-telangiectasia-like disorder in a family deficient for MRE11A, caused by a MRE11 variant. Neurol. Genet. 4, e295 (2018).","journal-title":"Neurol. Genet."},{"key":"1003_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81106-w","volume":"11","author":"IE Elkholi","year":"2021","unstructured":"Elkholi, I. E. et al. Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer. Sci. Rep. 11, 2409 (2021).","journal-title":"Sci. Rep."},{"key":"1003_CR77","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","volume":"22","author":"L Cast\u00e9ra","year":"2014","unstructured":"Cast\u00e9ra, L. et al. Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur. J. Hum. Genet. 22, 1305\u20131313 (2014).","journal-title":"Eur. J. Hum. Genet."},{"key":"1003_CR78","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","volume":"33","author":"FJ Couch","year":"2015","unstructured":"Couch, F. J. et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J. Clin. Oncol. 33, 304\u2013311 (2015).","journal-title":"J. Clin. Oncol."},{"key":"1003_CR79","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.1091496","volume":"304","author":"J-H Lee","year":"2004","unstructured":"Lee, J.-H. & Paull, T. T. Direct activation of the ATM protein kinase by the Mre11\/Rad50\/Nbs1 complex. Science 304, 93\u201396 (2004).","journal-title":"Science"},{"key":"1003_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00999-2","volume":"9","author":"Y Li","year":"2025","unstructured":"Li, Y., Yang, X., Cai, H. & Wang, F. Homologous recombination deficiency among patients with germline or somatic non-BRCA1\/2 homologous recombination repair gene variations. NPJ Precis. Oncol. 9, 192 (2025).","journal-title":"NPJ Precis. Oncol."},{"key":"1003_CR81","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747\u2013753 (2009).","journal-title":"Nature"},{"key":"1003_CR82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2013.03.002","volume":"153","author":"LA Garraway","year":"2013","unstructured":"Garraway, L. A. & Lander, E. S. Lessons from the Cancer Genome. Cell 153, 17\u201337 (2013).","journal-title":"Cell"},{"key":"1003_CR83","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMra0802968","volume":"359","author":"WD Foulkes","year":"2008","unstructured":"Foulkes, W. D. Inherited susceptibility to common cancers. N. Engl. J. Med. 359, 2143\u20132153 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1003_CR84","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature12981","volume":"505","author":"N Rahman","year":"2014","unstructured":"Rahman, N. Realizing the promise of cancer predisposition genes. Nature 505, 302\u2013308 (2014).","journal-title":"Nature"},{"key":"1003_CR85","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1101\/gad.14.9.1085","volume":"14","author":"B Kneitz","year":"2000","unstructured":"Kneitz, B. et al. MutS homolog 4 localization to meiotic chromosomes is required for chromosome pairing during meiosis in male and female mice. Genes Dev. 14, 1085\u20131097 (2000).","journal-title":"Genes Dev."},{"key":"1003_CR86","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1357-2725(01)00131-5","volume":"34","author":"HT Idriss","year":"2002","unstructured":"Idriss, H. T., Al-Assar, O. & Wilson, S. H. DNA polymerase \u03b2. Int. J. Biochem. Cell Biol. 34, 321\u2013324 (2002).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1003_CR87","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1074\/jbc.M113.530303","volume":"289","author":"M Cam","year":"2014","unstructured":"Cam, M. et al. p53\/TAp63 and AKT regulate mammalian target of Rapamycin Complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage. J. Biol. Chem. 289, 4083\u20134094 (2014).","journal-title":"J. Biol. Chem."},{"key":"1003_CR88","first-page":"1","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar, V. et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct. Target. Ther. 8, 1\u201325 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1003_CR89","doi-asserted-by":"publisher","first-page":"jcs228015","DOI":"10.1242\/jcs.228015","volume":"133","author":"ML Fisher","year":"2020","unstructured":"Fisher, M. L., Balinth, S. & Mills, A. A. p63-related signaling at a glance. J. Cell Sci. 133, jcs228015 (2020).","journal-title":"J. Cell Sci."},{"key":"1003_CR90","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/molecules24152805","volume":"24","author":"HR Stern","year":"2019","unstructured":"Stern, H. R., Sefcikova, J., Chaparro, V. E. & Beuning, P. J. Mammalian DNA polymerase Kappa activity and specificity. Molecules 24, 2805 (2019).","journal-title":"Molecules"},{"key":"1003_CR91","doi-asserted-by":"crossref","unstructured":"Vaisman, A. et al. Identification and characterization of thermostable Y-Family DNA Polymerases \u03b7, \u03b9, \u03ba and Rev1 from a lower Eukaryote, Thermomyces lanuginosus. Front. Mol. Biosci. 8, (2021).","DOI":"10.3389\/fmolb.2021.778400"},{"key":"1003_CR92","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1093\/nar\/gkad154","volume":"51","author":"T Huang","year":"2023","unstructured":"Huang, T. et al. SPIDR is required for homologous recombination during mammalian meiosis. Nucleic Acids Res. 51, 3855\u20133868 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1003_CR93","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000503715","volume":"14","author":"F Peintinger","year":"2019","unstructured":"Peintinger, F. National breast screening programs across Europe. Breast Care 14, 354\u2013358 (2019).","journal-title":"Breast Care"},{"key":"1003_CR94","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/1055-9965.EPI-22-0756","volume":"32","author":"N Mavaddat","year":"2023","unstructured":"Mavaddat, N. et al. Incorporating alternative polygenic risk scores into the BOADICEA breast cancer risk prediction model. Cancer Epidemiol. Biomark. Prev. 32, 422\u2013427 (2023).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1003_CR95","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee, A. et al. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet. Med. 21, 1708\u20131718 (2019).","journal-title":"Genet. Med."},{"key":"1003_CR96","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1158\/1055-9965.EPI-20-1319","volume":"30","author":"T Carver","year":"2021","unstructured":"Carver, T. et al. CanRisk Tool \u2013 A web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants. Cancer Epidemiol. Biomark. Prev. 30, 469\u2013473 (2021).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1003_CR97","doi-asserted-by":"publisher","first-page":"e0229999","DOI":"10.1371\/journal.pone.0229999","volume":"15","author":"S Archer","year":"2020","unstructured":"Archer, S. et al. Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study. PLOS ONE 15, e0229999 (2020).","journal-title":"PLOS ONE"},{"key":"1003_CR98","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1038\/s41586-021-03758-y","volume":"597","author":"S Gudmundsson","year":"2021","unstructured":"Gudmundsson, S. et al. Addendum: The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 597, E3\u2013E4 (2021).","journal-title":"Nature"},{"key":"1003_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye, J. et al. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinforma. 13, 134 (2012).","journal-title":"BMC Bioinforma."},{"key":"1003_CR100","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1003_CR101","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"1003_CR102","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. J. Am. Coll. Med. Genet. 17, 405\u2013424 (2015).","journal-title":"Genet. Med. J. Am. Coll. Med. Genet."},{"key":"1003_CR103","unstructured":"Sequence Variant Interpretation - ClinGen | Clinical Genome Resource. https:\/\/clinicalgenome.org\/working-groups\/sequence-variant-interpretation\/."},{"key":"1003_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-020-00230-y","volume":"12","author":"J Storer","year":"2021","unstructured":"Storer, J., Hubley, R., Rosen, J., Wheeler, T. J. & Smit, A. F. The Dfam community resource of transposable element families, sequence models, and genome annotations. Mob. DNA 12, 2 (2021).","journal-title":"Mob. DNA"},{"key":"1003_CR105","unstructured":"Bionano Access Software is the Perfect Companion to Saphyr. bionanogenomics https:\/\/bionano.com\/blogs\/bionano-access-software-perfect-companion-saphyr\/."},{"key":"1003_CR106","unstructured":"Recommendations | Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/cg164\/chapter\/recommendations#box-1-information-provision-for-people-with-concerns-about-familial-breast-cancer-risk (2013)."},{"key":"1003_CR107","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1136\/jmg-2023-109311","volume":"61","author":"P Baliakas","year":"2024","unstructured":"Baliakas, P. et al. Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer. J. Med. Genet. 61, 150\u2013154 (2024).","journal-title":"J. Med. Genet."},{"key":"1003_CR108","unstructured":"Sequence Variant Interpretation - ClinGen | Clinical Genome Resource. https:\/\/clinicalgenome.org\/working-groups\/sequence-variant-interpretation\/ (2025)."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01003-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01003-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01003-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:47:50Z","timestamp":1782852470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-01003-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-01003-1","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}